ID

27925

Description

Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT; ODM derived from: https://clinicaltrials.gov/show/NCT01833611

Link

https://clinicaltrials.gov/show/NCT01833611

Keywords

Versions (1)
  1. 12/5/17 12/5/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 5, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Hepatitis NCT01833611

English

Eligibility Chronic Hepatitis NCT01833611

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male and female subjects aged between 18 and 65 year-old with history of chronic hepatitis b virus infection;
Description

Age | Hepatitis B, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0524909
2. detectable hbsag at screening and for at least 24 weeks prior to screening or detectable hbsag for < 24 week and negative for igm core antibody and confirmation of chronic hepatitis on liver biopsy;
Description

Hepatitis B Surface Antigens Detectable | Hepatitis B core antibody IgM Negative | Chronic Hepatitis Biopsy of liver

Data type

boolean

Alias
UMLS CUI [1,1]
C0019168
UMLS CUI [1,2]
C3830527
UMLS CUI [2,1]
C0373849
UMLS CUI [2,2]
C1513916
UMLS CUI [3,1]
C0019189
UMLS CUI [3,2]
C0193388
3. alt should be within normal range in recent one year and at least twice, which are at least 3 month apart;
Description

Alanine aminotransferase normal Recently

Data type

boolean

Alias
UMLS CUI [1,1]
C0855620
UMLS CUI [1,2]
C0332185
4. normal alt at screening;
Description

Alanine aminotransferase normal Screening

Data type

boolean

Alias
UMLS CUI [1,1]
C0855620
UMLS CUI [1,2]
C0220908
5. screening hbv dna of more than 10^5 copies/ml by roche amplicortm pcr assay performed by the central laboratory;
Description

Hepatitis B DNA assay Polymerase Chain Reaction

Data type

boolean

Alias
UMLS CUI [1,1]
C1168025
UMLS CUI [1,2]
C0032520
6. evidence of chronic hepatitis on liver biopsy (knodell hai score >= 4) performed ≤ 52 weeks prior to randomization;
Description

Chronic Hepatitis Biopsy of liver | Other Coding Score

Data type

boolean

Alias
UMLS CUI [1,1]
C0019189
UMLS CUI [1,2]
C0193388
UMLS CUI [2,1]
C3846158
UMLS CUI [2,2]
C0449820
7. all women of childbearing potential must have a negative serum or urine pregnancy test.
Description

Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0430061
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0430057
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. coinfection with human immunodeficiency virus (hiv), hepatitis c virus (hcv), or hepatitis d virus (hdv);
Description

HIV coinfection | HCV coinfection | HDV Coinfection

Data type

boolean

Alias
UMLS CUI [1]
C4062778
UMLS CUI [2]
C1698259
UMLS CUI [3,1]
C0011220
UMLS CUI [3,2]
C0275524
2. other forms of liver disease e.g., alcoholic, autoimmune, biliary disease;
Description

Liver diseases | Alcoholic Liver Diseases | Autoimmune liver disease | Hepatobiliary disease

Data type

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0023896
UMLS CUI [3]
C0400936
UMLS CUI [4]
C0267792
3. patients with evidence of decompensation of liver disease;
Description

Liver disease Decompensated

Data type

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C0205434
4. therapy with interferon, thymosin alpha or antiviral agents with activity against hepatitis b (e.g., adefovir, famciclovir, lamivudine, and telbivudine) within 24 weeks of randomization into this study;
Description

Interferon | thymalfasin | Antiviral Agents Hepatitis B | adefovir | famciclovir | Lamivudine | telbivudine

Data type

boolean

Alias
UMLS CUI [1]
C3652465
UMLS CUI [2]
C0076612
UMLS CUI [3,1]
C0003451
UMLS CUI [3,2]
C0019163
UMLS CUI [4]
C0050175
UMLS CUI [5]
C0209227
UMLS CUI [6]
C0209738
UMLS CUI [7]
C1453933
5. more than 12 weeks of prior therapy with nucleoside or nucleotide analogue antiviral agents with activity against hepatitis b (e.g., adefovir, famciclovir lamivudine, and telbivudine);
Description

Nucleoside Analogs | Nucleotide analog | Antiviral Agents Hepatitis B | adefovir | famciclovir | Lamivudine | telbivudine

Data type

boolean

Alias
UMLS CUI [1]
C1579410
UMLS CUI [2]
C0597107
UMLS CUI [3,1]
C0003451
UMLS CUI [3,2]
C0019163
UMLS CUI [4]
C0050175
UMLS CUI [5]
C0209227
UMLS CUI [6]
C0209738
UMLS CUI [7]
C1453933
6. prior therapy with entecavir;
Description

entecavir

Data type

boolean

Alias
UMLS CUI [1]
C0971023
7. known history of allergy to nucleoside analogues;
Description

Hypersensitivity Nucleoside Analogs

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1579410
8. hemoglobin < 10.0 g/dl;
Description

Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0518015
9. platelet count < 75,000/mm3;
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
10. absolute neutrophil count< 1500 cells/mm3;
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
11. creatinine > 1.5mg/dl (133 μmol/l);
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
12. anti-nuclear antibody (ana) titer > l :160 unless attributable to non-hepatic disease.
Description

Anti-nuclear antibody measurement

Data type

boolean

Alias
UMLS CUI [1]
C0587178
Back to the top of the page

Similar models

Eligibility Chronic Hepatitis NCT01833611

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age | Hepatitis B, Chronic
Item
1. male and female subjects aged between 18 and 65 year-old with history of chronic hepatitis b virus infection;
boolean
C0001779 (UMLS CUI [1])
C0524909 (UMLS CUI [2])
Hepatitis B Surface Antigens Detectable | Hepatitis B core antibody IgM Negative | Chronic Hepatitis Biopsy of liver
Item
2. detectable hbsag at screening and for at least 24 weeks prior to screening or detectable hbsag for < 24 week and negative for igm core antibody and confirmation of chronic hepatitis on liver biopsy;
boolean
C0019168 (UMLS CUI [1,1])
C3830527 (UMLS CUI [1,2])
C0373849 (UMLS CUI [2,1])
C1513916 (UMLS CUI [2,2])
C0019189 (UMLS CUI [3,1])
C0193388 (UMLS CUI [3,2])
Alanine aminotransferase normal Recently
Item
3. alt should be within normal range in recent one year and at least twice, which are at least 3 month apart;
boolean
C0855620 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Alanine aminotransferase normal Screening
Item
4. normal alt at screening;
boolean
C0855620 (UMLS CUI [1,1])
C0220908 (UMLS CUI [1,2])
Hepatitis B DNA assay Polymerase Chain Reaction
Item
5. screening hbv dna of more than 10^5 copies/ml by roche amplicortm pcr assay performed by the central laboratory;
boolean
C1168025 (UMLS CUI [1,1])
C0032520 (UMLS CUI [1,2])
Chronic Hepatitis Biopsy of liver | Other Coding Score
Item
6. evidence of chronic hepatitis on liver biopsy (knodell hai score >= 4) performed ≤ 52 weeks prior to randomization;
boolean
C0019189 (UMLS CUI [1,1])
C0193388 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2,1])
C0449820 (UMLS CUI [2,2])
Childbearing Potential Serum pregnancy test negative | Childbearing Potential Urine pregnancy test negative
Item
7. all women of childbearing potential must have a negative serum or urine pregnancy test.
boolean
C3831118 (UMLS CUI [1,1])
C0430061 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0430057 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
HIV coinfection | HCV coinfection | HDV Coinfection
Item
1. coinfection with human immunodeficiency virus (hiv), hepatitis c virus (hcv), or hepatitis d virus (hdv);
boolean
C4062778 (UMLS CUI [1])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
Liver diseases | Alcoholic Liver Diseases | Autoimmune liver disease | Hepatobiliary disease
Item
2. other forms of liver disease e.g., alcoholic, autoimmune, biliary disease;
boolean
C0023895 (UMLS CUI [1])
C0023896 (UMLS CUI [2])
C0400936 (UMLS CUI [3])
C0267792 (UMLS CUI [4])
Liver disease Decompensated
Item
3. patients with evidence of decompensation of liver disease;
boolean
C0023895 (UMLS CUI [1,1])
C0205434 (UMLS CUI [1,2])
Interferon | thymalfasin | Antiviral Agents Hepatitis B | adefovir | famciclovir | Lamivudine | telbivudine
Item
4. therapy with interferon, thymosin alpha or antiviral agents with activity against hepatitis b (e.g., adefovir, famciclovir, lamivudine, and telbivudine) within 24 weeks of randomization into this study;
boolean
C3652465 (UMLS CUI [1])
C0076612 (UMLS CUI [2])
C0003451 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
C0050175 (UMLS CUI [4])
C0209227 (UMLS CUI [5])
C0209738 (UMLS CUI [6])
C1453933 (UMLS CUI [7])
Nucleoside Analogs | Nucleotide analog | Antiviral Agents Hepatitis B | adefovir | famciclovir | Lamivudine | telbivudine
Item
5. more than 12 weeks of prior therapy with nucleoside or nucleotide analogue antiviral agents with activity against hepatitis b (e.g., adefovir, famciclovir lamivudine, and telbivudine);
boolean
C1579410 (UMLS CUI [1])
C0597107 (UMLS CUI [2])
C0003451 (UMLS CUI [3,1])
C0019163 (UMLS CUI [3,2])
C0050175 (UMLS CUI [4])
C0209227 (UMLS CUI [5])
C0209738 (UMLS CUI [6])
C1453933 (UMLS CUI [7])
entecavir
Item
6. prior therapy with entecavir;
boolean
C0971023 (UMLS CUI [1])
Hypersensitivity Nucleoside Analogs
Item
7. known history of allergy to nucleoside analogues;
boolean
C0020517 (UMLS CUI [1,1])
C1579410 (UMLS CUI [1,2])
Hemoglobin measurement
Item
8. hemoglobin < 10.0 g/dl;
boolean
C0518015 (UMLS CUI [1])
Platelet Count measurement
Item
9. platelet count < 75,000/mm3;
boolean
C0032181 (UMLS CUI [1])
Absolute neutrophil count
Item
10. absolute neutrophil count< 1500 cells/mm3;
boolean
C0948762 (UMLS CUI [1])
Creatinine measurement, serum
Item
11. creatinine > 1.5mg/dl (133 μmol/l);
boolean
C0201976 (UMLS CUI [1])
Anti-nuclear antibody measurement
Item
12. anti-nuclear antibody (ana) titer > l :160 unless attributable to non-hepatic disease.
boolean
C0587178 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial